Cell Transformation Assays as Predictors of Human Carcinogenicity
Robert D. Combes(Fund for the Replacement of Animals in Medical Experiments), Hiroshi Yamasaki(Museum für Naturkunde), Robert A. LeBœuf(Procter & Gamble (Belgium)), Noriho Tanaka(Food and Drug Safety Center), Edgar Rivedal(Norwegian Food Safety Authority), Michael Balls(Joint Research Centre), C Lasne(Ministère de l'Agriculture et de la Souveraineté alimentaire), Michel Fischbach(Hôpital d'Hautepierre), Norbert E. Fusenig(German Cancer Research Center), Lutz Müller(Roche (Switzerland)), David Kirkland(Covance (United States)), Joseph R. Landolph(University of Southern California), Hans Marquardt(Nara Medical University), Enrico Sabbioni(Joint Research Centre), J. Justin McCormick(Michigan State University), Rodger Curren(Institute for In Vitro Sciences), Paule Vasseur(Unknown)
Cited by 86
Related Papers
COMMENTARY: Role of connexin genes in growth control
|Carcinogenesis|1996|457
How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2007|437
Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients
|Arthritis & Rheumatology|2014|430
The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association
|Immunity|1995|314
Antioxidant Biomarkers in Freshwater Bivalves, Unio tumidus, in Response to Different Contamination Profiles of Aquatic Sediments
|Ecotoxicology and Environmental Safety|2000|233